“It cannot be that we only innovate in science and that we can’t innovate in the ways we do business and how we shape health care systems.” In this latest instalment of the In Vivo podcast, Claus Zieler, chief commercial officer at Astellas Pharma, puts out a call to action for industry to better collaborate with regulators to improve access to medicines in a more efficient manner.
Zieler discusses the shift in health care models from chronic disease management to potential one-off treatments, and the impact of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?